Genmab — Juli 2020

[E_L]

DnB Markets
Rune Majlund Dahl
Genmab (Hold, TP: DKK2400.00) - Limited Covid-19 impact
We expect slightly lower Darzalex sales in Q2 QOQ due to Covid-19, and estimate global sales of USD936m. We are at the mid-point of the USD3.9bn–4.2bn sales guidance for 2020e.

[E_L]

https://twitter.com/Genmab/status/1282637185615896579

[Solsen]

Thanks I see JW is still CEO

[E_L]

[Mcjean]

Søg job på Jyllandsposten, din analyse er klart skarpere end deres!

[E_L]

another PET/CT Scan trial With the Radioactive Tracer 89Zr-DFO-Daratumumab https://clinicaltrials.gov/ct2/show/NCT04467281?term=genmab+OR+daratumumab+OR+darzalex+OR+ofatumumab+OR+Teprotumumab+OR+Tisotumab+OR+camidanlumab+OR+Enapotamab+OR+ADCT-301+OR+duobody&lupd_s=07%2F13%2F2020&draw=2&rank=1

[gdn55]

Nå, det gik jo ikke så galt idag alligevel.

[Helge_LarsenPI-redaktør]

Servicemeddelse: Jeg har lavet to chats til Finans- og Økonomikalendere. Jeg opdaterer disse løbende frem over.

[Helge_LarsenPI-redaktør]

God morgen.

[Helge_LarsenPI-redaktør]

Pensionist...Det er i kronogisk orden, men er svært at læse. Det bliver bedre. Det er foreløbigt blot en test. Det er meningen at der kun bliver slået en dag ad gangen op. Det er mere overskueligt.

[Helge_LarsenPI-redaktør]

Foreløbigt er det en nødløsning til vi får råd til en bedre teknisk løsning.

[E_L]

An evaluation of subcutaneous daratumumab for the treatment of multiple myeloma
https://www.tandfonline.com/doi/full/10.1080/17474086.2020.1795829

[E_L]

full article https://sci-hub.tw/https://www.tandfonline.com/doi/full/10.1080/17474086.2020.1795829 i suggest reading at least the conclusion and expert opinion

[Helge_LarsenPI-redaktør]

Thanks E L.

[Helge_LarsenPI-redaktør]

Expert opinion

"
Subcutaneous daratumumab is non-inferior to conventional intravenous daratumumab with lower risk of infusion-related reactions and decreased administration time. Based on these data, and the recent FDA and European Commission approvalsthe widespread use of the subcutaneous formulation for both conventional and investigational practice is supported".

[Helge_LarsenPI-redaktør]

The link to the full article do not function for me.

[Bulder]

It's because it's sci-hub. No access from Denmark.

[Helge_LarsenPI-redaktør]

Ok.

[E_L]

"Additionally, the decreased
infusion time should translate to improved quality of life, less healthcare resource use, and increased
economic benefit in terms of decreased time away from work and increased productivity."

[Helge_LarsenPI-redaktør]

Pharma og biotek under pres som så meget andet her i åbningen.